KoBioLabs, Inc (KOSDAQ:348150)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,835.00
-140.00 (-4.71%)
At close: Sep 3, 2026

KoBioLabs Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-4,804-6,330-5,298-13,853-21,921-15,382
Depreciation & Amortization
2,7932,7772,5781,515908.06232.72
Loss (Gain) From Sale of Assets
--123.43-6.85-
Loss (Gain) From Sale of Investments
-62.4-191.75---11.51-7.33
Stock-Based Compensation
274.19190.7265.42800.351,6951,571
Other Operating Activities
-980.08-343.23942.99-2,4083,127-704.12
Change in Accounts Receivable
-1,888-1,203-950.57-1,266-702.542,478
Change in Inventory
-2,078-1,040-3,202-487.87-725.03-150.65
Change in Accounts Payable
894.97-1.252.62---
Change in Unearned Revenue
---5.45-114.78-512.29361.64
Change in Other Net Operating Assets
3,404356.781,1881,9821,580-880.97
Operating Cash Flow
-2,446-5,784-4,355-13,832-16,556-12,481
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-404.15-296.78-1,640-15,133-14,683-5,512
Sale of Property, Plant & Equipment
--1.210.81--
Sale (Purchase) of Intangibles
-147.13-256.13-6.5-428.32-81.81-39.07
Investment in Securities
8,02710,1386,11323,960-46,421-25,454
Other Investing Activities
260.96-137.031,967-217.46-748.86-19.09
Investing Cash Flow
7,7369,4486,4348,192-61,814-31,154

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-6,8004,800---
Long-Term Debt Issued
-3,5003,2004,0006,05913,346
Total Debt Issued
10,30010,3008,0004,0006,05913,346
Short-Term Debt Repaid
--4,500-1,075---
Long-Term Debt Repaid
--9,298-13,582-339.15-95.54-39.3
Total Debt Repaid
-7,616-13,798-14,657-339.15-95.54-39.3
Net Debt Issued (Repaid)
2,684-3,498-6,6573,6615,96413,307
Issuance of Common Stock
-112.75151.32395.1710,7504,350
Other Financing Activities
00-7.48-9.8919,596-0
Financing Cash Flow
2,684-3,386-6,5134,04636,31055,741

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-1,211-1,37376.261,208-199.67-40.36
Net Cash Flow
6,763-1,095-4,358-386.23-42,26012,066

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-2,851-6,081-5,995-28,966-31,239-17,993
Free Cash Flow Growth
------
Free Cash Flow Margin
-3.78%-8.78%-8.77%-87.41%-269.17%-621.88%
Free Cash Flow Per Share
-146.80-313.32-312.34-1563.45-1859.88-1121.36
Levered Free Cash Flow
-3,093-6,010-11,457-20,874-24,552-16,000
Unlevered Free Cash Flow
-2,791-5,689-10,733-19,916-23,501-15,904

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
468.49532.41670.65303.02140.638.88
Cash Income Tax Paid
--154.0615.9249.35239.81180.4
Change in Working Capital
332.92-1,887-2,967113.36-359.911,808